Petmed Express Inc: Form 10-Q for the period ended Jun 30, 2025
Filed with the SEC on Dec 19, 2025 and accepted by EDGAR at Dec 19, 2025, 16:39 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-04-01 to 2025-06-30 | $51.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2025-04-01 to 2025-06-30 | $36.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-04-01 to 2025-06-30 | $14.4m | us-gaap:GrossProfit |
| Operating income | 3 months2025-04-01 to 2025-06-30 | −$34.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-04-01 to 2025-06-30 | $9.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-04-01 to 2025-06-30 | −$34.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-04-01 to 2025-06-30 | −$1.65 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-04-01 to 2025-06-30 | −$1.65 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-04-01 to 2025-06-30 | 20,755,416 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2025-04-01 to 2025-06-30 | −$12.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2025-04-01 to 2025-06-30 | $1.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2025-04-01 to 2025-06-30 | $1.0k | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2025-06-30 | $41.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-06-30 | $67.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-06-30 | $109.8m | us-gaap:Assets |
| Current liabilities | At period end2025-06-30 | $57.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-06-30 | $58.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-06-30 | $51.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001040130-25-000106. Last ingested by Listed: Nov 6, 2026, 18:20 ET. Listed shows no prices and gives no investment advice.